041830.KQ
InBody Co.,Ltd
KOE · Healthcare · Medical - Specialties · KR
KRW 59,600.00
+1.19%Year over year
Reported trailing growth
- Revenue
- +21.3%
- EBITDA
- -24.2%
- EBIT
- +43.7%
- EPS
- +47.2%
- Free cash flow
- +62.1%
- Operating cash flow
- +47.9%
Forward estimates
Based on analyst estimates
- Revenue
- -45.5%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +13.5%
- EBITDA
- -2.3%
- EBIT
- -3.9%
- Net income
- -3.2%
- EPS
- -2.3%
- Free cash flow
- +5.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026